Ibaraki, Japan

Tetsuhiro Niidome

This inventor holds 2 USPTO granted patents. Top assignee: Eisai Company, Limited. Active years: 2004-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tetsuhiro Niidome. Retrieved from https://idiyas.com/inventor/tetsuhiro-niidome-bq9eza9z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2004-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tetsuhiro Niidome: Innovator in Pharmaceutical Chemistry

Introduction

Tetsuhiro Niidome is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative compounds. With a total of 2 patents, Niidome's work focuses on developing novel compounds that exhibit unique properties.

Latest Patents

One of his latest patents is centered around a piperazine compound and a pharmaceutical composition containing this compound. The invention provides a novel compound that demonstrates superior calcium antagonism, specifically neuron-selective calcium antagonism. The compound is represented by a specific formula, which includes various components such as aromatic rings and cyclic amine derivatives.

Career Highlights

Tetsuhiro Niidome is currently associated with Eisai Company, Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating compounds that have potential therapeutic applications.

Collaborations

Niidome has collaborated with notable colleagues, including Noboru Yamamoto and Yuichi Suzuki, to further enhance the impact of his research in the pharmaceutical industry.

Conclusion

Tetsuhiro Niidome's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…